research

The making of South Korea's COVID-19 test success. IES Policy Brief Issue 2020/04 - April 2020

Abstract

At least 120 countries have asked South Korea for COVID-19 test kits and other materials to fight against the ongoing coronavirus pandemic. South Korean biotech firms are shipping the kits everywhere from Europe and the United States to the Middle East and Southeast Asia. The secret to South Korea’s test development and manufacturing success lies in Daejeon. This city is home to Daedeok Innopolis, South Korea’s main R&D cluster, including for biotech. Developed since the 1990s, South Korea’s biotech industry is a textbook case of the country’s industrial policy. It is based on two pillars: public-private cooperation and continuity across administrations. This is what Daedeok Innopolis and South Korea’s COVID-19 test success embody

    Similar works